Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: A randomized controlled clinical trial

Journal of Periodontology

Volumn 83, Issue 9, 2012, Pages 1155-1163

  Agarwal, Esha ^a   Pradeep, A R ^a   Bajaj, Pavan ^a   Naik, Savitha B ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Clarithromycin; Inflammation; Periodontitis; Root planing; Smoking; Statistics

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN; PLACEBO;

ADULT; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; GEL; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; SMOKING; TOOTH PLAQUE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; CHRONIC PERIODONTITIS; CLARITHROMYCIN; DELAYED-ACTION PREPARATIONS; DENTAL PLAQUE INDEX; DENTAL SCALING; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; GELS; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PLACEBOS; ROOT PLANING; SMOKING; TREATMENT OUTCOME;

EID: 84865972160     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110600     Document Type: Article

References (41)

1. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111.
2. Persson RE, Hollender LG, Persson GR. Assessment of alveolar bone levels from intraoral radiographs in subjects between ages 15 and 94 years seeking dental care. J Clin Periodontol 1998;25:647-654.
3. Norderyd O, Hugoson A. Risk of severe periodontal disease in a Swedish adult population. A cross-sectional study. J Clin Periodontol 1998;25:1022-1028.
4. Axelsson P, Paulander J, Lindhe J. Relationship between smoking and dental status in 35-, 50-, 65-, and 75-year-old individuals. J Clin Periodontol 1998; 25:297-305.
5. Machtei EE, Hausmann E, Dunford R, et al. Longitudinal study of predictive factors for periodontal disease and tooth loss. J Clin Periodontol 1999;26:374-380.
6. Bergström J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989;17:245-247.
7. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993;64:16-23.
8. Preber H, Bergström J. The effect of non-surgical treatment on periodontal pockets in smokers and non-smokers. J Clin Periodontol 1986;13:319-323.
9. Haffajee AD, Socransky SS. Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 2001;28:377-388.
10. Palmer RM, Matthews JP, Wilson RF. Non-surgical periodontal treatment with and without adjunctive metronidazole in smokers and non-smokers. J Clin Periodontol 1999;26:158-163.
11. Haffajee AD, Dibart S, Kent RL Jr, Socransky SS. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol 1995;22:618-627.
12. Greenstein G. Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases. J Periodontol 1995;66:925-932.
13. Jorgensen MG, Slots J. Responsible use of antimicrobials in periodontics. J Calif Dent Assoc 2000;28:185-193.
14. Soskolne WA. Subgingival delivery of therapeutic agents in the treatment of periodontal diseases. Crit Rev Oral Biol Med 1997;8:164-174.
15. Killoy WJ. Chemical treatment of periodontitis: Local delivery of antimicrobials. Int Dent J 1998;48(Suppl. 1):305-315.
16. Preshaw PM, Hefti AF, Bradshaw MH. Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol 2005;32:610-616.
17. Tomasi C, Wennström JL. Locally delivered doxycycline improves the healing following non-surgical periodontal therapy in smokers. J Clin Periodontol 2004; 31:589-595.
18. Williams JD, Maskell JP, Shain H, et al. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptog-ramin RP 59500 against oral organisms. J Antimicrob Chemother 1992;30:27-37.
19. Miyake YK, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. J Periodontal Res 1995;30:290-293.
20. Moore PA. Dental therapeutic indications for the newer long-acting macrolide antibiotics. J Am Dent Assoc 1999;130:1341-1343.
21. Scaglione F, Demartini G, Dugnani S, Fraschini F. A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. Chemotherapy 1993;39:416-423.
22. Chou CH, Walters JD. Clarithromycin transport by gingival fibroblasts and epithelial cells. J Dent Res 2008;87:777-781.
23. Amsden GW. Anti-inflammatory effects of macrolides - An underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005;55:10-21.
24. Anderson R, Joone G, van Rensburg CE. An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent. J Antimicrob Chemother 1988;22:923-933.
25. Ives TJ, Schwab UE, Ward ES, Butts JD, Hall IH. Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions. Res Commun Mol Pathol Pharmacol 2001; 110:183-208.
26. Pradeep AR, Sagar SV, Daisy H. Clinical and micro-biologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. J Periodontol 2008;79:2125-2135.
27. Pradeep AR, Kathariya R. Clarithromycin, as an adjunct to non surgical periodontal therapy for chronic peri-odontitis: A double blinded, placebo controlled, randomized clinical trial. Arch Oral Biol 2011;56:1112-1119.
28. Kamma JJ, Giannopoulou C, Vasdekis VGS, Mombelli A. Cytokine profile in gingival crevicular fluid of aggressive periodontitis: Influence of smoking and stress. J Clin Periodontol 2004;31:894-902.
29. Quigley GA, Hein JW. Comparative cleansing efficiency of manual and power brushing. J Am Dent Assoc 1962;65:26-29.
30. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol 1970;41:41-43.
31. Löe H, Silness J. Periodontal diseases in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
32. Mombelli A, van Oosten MA, Schurch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
33. Shah NH, Railkar AS, Chen FC, Tarantino R, Kumar S, Murjani M. A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic coglycolic) acid (PLGA) copolymers. J Control Release 1993;27:139-147.
34. Bergström J, Preber H. Tobacco use as a risk factor. J Periodontol 1994;65(Suppl. 5):545-550.
35. Pindborg JJ. Tobacco and gingivitis: Statistical examination of the significance of tobacco in the development of ulceromembranous gingivitis and in the formation of calculus. J Dent Res 1947;26:261-264.
36. Goodson JM, Hogan PE, Dunham SL. Clinical responses following periodontal treatment by local drug delivery. J Periodontol 1985;56(Suppl. 11):81-87.
37. Needleman IG, Pandya NV, Smith SR, Foyle DM. The role of antibiotics in the treatment of periodontitis (Part 2 - Controlled drug delivery). Eur J Prosthodont Restor Dent 1995;3:111-117.
38. Kornman KS. Controlled-release local delivery antimicrobials in periodontics: Prospects for the future. J Periodontol 1993;64(Suppl. 8):782-791.
39. Burrell RC, Walters JD. Distribution of systemic clarithromycin to gingiva. J Periodontol 2008;79:1712-1718.
40. M Shaddox L, Andia DC, Casati MZ, et al. Microbiologic changes following administration of locally delivered doxycycline in smokers: A 15-month follow-up. J Periodontol 2007;78:2143-2149.
41. Machion L, Andia DC, Saito D, et al. Microbiological changes with the use of locally delivered doxycycline in the periodontal treatment of smokers. J Periodontol 2004;75:1600-1604.